+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 18Years +
All Genders
ID07567833

Study of Retinal Function Changes in Diabetic Macular Edema Treated with Anti-VEGF Injections

Led by Jaeb Center for Health Research · Updated on 2026-10-23

100

Participants Needed

8

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying diabetic retinal disease, focusing on eyes treated for diabetic macular edema DME with anti-VEGF agents. The study aims to better understand retinal structural and functional changes in people with diabetes to develop and validate new clinical and surrogate endpoints. This is important because current endpoints require long trials and many participants to show treatment effects. Participants will receive injections of anti-vascular endothelial growth factor anti-VEGF at baseline, 4, and 8 weeks. Afterward, they will be monitored every 8 weeks, and injections will continue only if the eye shows center-involved DME or visual acuity worse than 2020 due to DME. Participants may be assessed more frequently if symptoms occur. The study includes three groups based on severity of center-involved DME. During the study, participants will undergo various assessments including multifocal pupillographic objective perimetry, contrast sensitivity, electroretinography, reading performance, visual field function, diabetic retinopathy severity, retinal vascular pathology, retinal structure, and microvascular parameters. These measures will be tracked from baseline up to one year to evaluate changes. The study runs from July 2026 to December 2027 and involves adult participants with diabetic retinal disease.

CONDITIONS

Brief Title

Longitudinal Study of Retinal Function in Eyes Treated for Diabetic Macular Edema With Anti-VEGF Agents

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here